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ABCC9-related Intellectual disability
Myopathy Syndrome is a KATP channelopathy
with loss-of-function mutations in ABCC9
Marie F. Smeland1,16*, Conor McClenaghan2,16, Helen I. Roessler 3,16, Sanne Savelberg3,
Geir Åsmund Myge Hansen1, Helene Hjellnes1, Kjell Arne Arntzen4,5,6, Kai Ivar Müller 4,5,
Andreas Rosenberger Dybesland6,7, Theresa Harter2, Monica Sala-Rabanal2,14, Chris H. Emﬁnger2,
Yan Huang2,15, Soma S. Singareddy2, Jamie Gunn8, David F. Wozniak8, Attila Kovacs9, Maarten Massink3,
Federico Tessadori 3,10, Sarah M. Kamel 10, Jeroen Bakkers 10,11, Maria S. Remedi12,
Marijke Van Ghelue1,13,17, Colin G. Nichols 2,17 & Gijs van Haaften3,17*

Mutations in genes encoding KATP channel subunits have been reported for pancreatic disorders and Cantú syndrome. Here, we report a syndrome in six patients from two families
with a consistent phenotype of mild intellectual disability, similar facies, myopathy, and
cerebral white matter hyperintensities, with cardiac systolic dysfunction present in the two
oldest patients. Patients are homozygous for a splice-site mutation in ABCC9 (c.1320 + 1 G >
A), which encodes the sulfonylurea receptor 2 (SUR2) subunit of KATP channels. This
mutation results in an in-frame deletion of exon 8, which results in non-functional KATP
channels in recombinant assays. SUR2 loss-of-function causes fatigability and cardiac dysfunction in mice, and reduced activity, cardiac dysfunction and ventricular enlargement in
zebraﬁsh. We term this channelopathy resulting from loss-of-function of SUR2-containing
KATP channels ABCC9-related Intellectual disability Myopathy Syndrome (AIMS). The phenotype differs from Cantú syndrome, which is caused by gain-of-function ABCC9 mutations,
reﬂecting the opposing consequences of KATP loss- versus gain-of-function.
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ATP channels are nucleotide-gated potassium channels
formed by the obligate co-assembly of pore-forming Kir6.x
subunits and regulatory sulfonylurea receptors (SURx),
which couple the membrane potential to metabolic state in
multiple cell types1,2. In mammals, two Kir6.x isoforms are
encoded by the paralogous KCNJ8 (Kir6.1; [OMIM: 600935]) and
KCNJ11 (Kir6.2; [OMIM: 600937]) genes, which are each colocated with genes encoding two SUR isoforms, ABCC9 (SUR2;
[OMIM: 601439]) and ABCC8 (SUR1; [OMIM: 600509]),
respectively, on chromosomes 12 and 11. Molecular heterogeneity
is further increased by alternative splicing of ABCC9 mRNA,
yielding two major splice variants, SUR2A and SUR2B— while
multiple other splice variants have also been reported1,3–8. Pancreatic and neuronal KATP channels are predominantly formed by
Kir6.2 and SUR1, smooth muscle KATP channels are comprised of
Kir6.1 and SUR2B, and the predominant combination in striated
muscle is Kir6.2 and SUR2A3.
The causative role of gain-of-function (GoF) or loss-offunction (LoF) mutations in the Kir6.2/SUR1-dependent pancreatic KATP channels in neonatal diabetes and congenital
hyperinsulinism, respectively, was established nearly two decades
ago9–12. Recently, it has been demonstrated that dominant GoF
mutations in KCNJ8 and ABCC9 underlie Cantú Syndrome (CS
[OMIM: 239850])13–15. CS is characterized by hypertrichosis,
coarse facial features, and multiple cardiovascular abnormalities,
including cardiomegaly and tortuous, dilated vasculature14–16.
Behavioral problems and mild developmental delay have been
reported in CS, but intellectual function is typically normal17.
The human consequences of LoF in Kir6.1 and SUR2 remain
uncertain. In a single report, two heterozygous LoF mutations in
an exon found only in SUR2A were associated with dilated cardiomyopathy (DCM [MIM: 608569])18. A missense mutation in
the same exon was reported as predisposing to paroxystic adrenergic atrial ﬁbrillation (AF [MIM: 614050]), but only in one 53year-old female patient19. The pathophysiological consequences
of complete SUR2 LoF are unclear.
We report six patients from two non-consanguineous families
from Northern Norway who exhibit a shared pathological constellation including similar facies, intellectual disability and
developmental delay, anxiety, myopathy with hypotonia, muscle
weakness, and fatigability. Cardiac systolic dysfunction is found
in the two oldest patients. All have cerebral white matter
hyperintensities, and hyperreﬂexia is found in the oldest four. The
families are investigated by comprehensive clinical exome
sequencing, a powerful tool for identifying the genetic basis of
rare and complex syndromes, both in patients with de novo
mutations and in families with suspected recessive
inheritance20,21.
We identify a homozygous ABCC9 splice site mutation
(c.1320 + 1 G > A) in all affected individuals. We show that the
mutation causes the in-frame deletion of exon 8, resulting in
SUR2 protein lacking 52 amino acids, and loss of plasmalemmal
KATP function. Using CRISPR/Cas9 genome engineering, we
introduce frameshift mutations into ABCC9 that result in premature protein truncation, in both zebraﬁsh and mice. These
animals lack functional SUR2 protein and myocyte KATP
channels and recapitulate the myopathy and cardiac dysfunction
observed in patients. We conclude that SUR2 LoF results in a
recessive syndrome: ABCC9-related Intellectual disability Myopathy Syndrome (AIMS).

Results
Patient descriptions. Four siblings from Family 1 (aged 12–21
years) and two siblings from Family 2 (aged 29, 33) (Fig. 1a) are
described. The families are not known to be related, but are from
2

the same area of Northern Norway. Genetic investigations had
earlier been performed with normal results in several of the
patients, including G-banding, high-resolution Single-Nucleotide
Polymorphism (SNP) array to look for genomic deletions and
duplications, FMRI CGG repeat analysis, DMPK PCR, sequencing of multiple neuromuscular disease genes, screening for
mitochondrial DNA sequence variants/deletions, and screening
for inborn errors of metabolism. Clinical photographs of the
patients are presented in Fig. 1b, c. MRI images are presented in
Fig. 1d. Clinical features are summarized in Tables 1 and 2.
Family 1. Patient 1–1 is the ﬁrst child of healthy parents from
Northern Norway with probable Finnish ancestry. Pregnancy and
birth were uneventful. Weight and length were below the 2.5
percentile in childhood. Hearing loss was reported in childhood,
but a recent hearing evaluation was normal. Early psychomotor
development was described as normal, but at age 2, in-toeing, toewalking and reduced ﬁne motor skills, generalized hypotonia,
lumbar lordosis, and delayed development were noted. At age 11,
neuropsychological testing identiﬁed mild intellectual disability.
From age 15, she experienced episodes of tonic/tonic–clonic
seizures, but epileptic activity was absent in repeated EEGs.
Lamotrigine treatment was partly effective. She continues to
report muscular pain, fatigue, and anxiety. Recently, hyperprolactinemia was found (720 mlU L−1 (ref: 102–496 mlU L−1)). An
MRI of the pituitary, however, did not disclose pituitary adenomas. She lives in her own home, but requires frequent supervision
and help. For neuromuscular evaluation of all patients, including
cerebral MRI with white matter changes, see Tables 1 and 2.
Patient 1–2 is the younger brother of 1–1. Pregnancy and birth
were uneventful. Delayed psychomotor development and lumbar
lordosis was noted early alongside eating difﬁculties and low body
weight. In childhood, he displayed left lower extremity weakness,
hyperreﬂexia, and limping. Muscle biopsy showed unspeciﬁc
changes of mitochondrial aggregation and muscle ﬁber caliber
variation. Mild intellectual disability was diagnosed by neuropsychological testing in teenage years.
Patient 1–3 is the younger brother of 1–1. Pregnancy and birth
were unremarkable. He showed delayed early psychomotor
development with generalized hypotonia and toe-walking.
Hyperreﬂexia was noted in the lower extremities from age 5.
Eating difﬁculties, nausea, abdominal pain, and low body weight
were present from childhood. Neuropsychological testing at 5
years showed mild intellectual disability. Profound muscular
pain and stiffness are reported after physical exercise. Mild
bilateral high-frequency sensorineural hearing loss was found at
age 12.
Patient 1–4 is the youngest brother of 1–1. Pregnancy and birth
were unremarkable. Eating difﬁculties and low body weight were
observed in early years, with weight and length at the 2.5
percentile. Delayed psychomotor development, in-toeing, lumbar
lordosis, generalized muscular hypotonia, and strabismus were
noted. At age 7, he experienced a cerebral episode with coma and
tetraplegia preceded directly by repeated vomiting, and a few days
earlier by high fever. Serum measurements showed a metabolic
acidosis with S-lactate 6, normal S-potassium (measured after
intravenous infusion), and elevated S-creatin kinase (738) at
hospital admission. Cerebral MRI revealed multiple lesions in
both hemispheres periventricularly, subcortically, in the pons and
the basal ganglia, in both gray and white matter. Acute
disseminated encephalomyelitis was discussed, and steroid
treatment was given. He regained consciousness over the
following few days. Re-evaluation of MRI ﬁndings concluded
with an “inﬂammatory perivascular reaction”. MRI lesions were
normalized a few weeks later, except for a white matter lesion by
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Fig. 1 Clinical features and pedigrees of AIMS patients. a Pedigrees of both affected families. Black deﬁnes patients homozygous for the ABCC9 c.1320 + 1
G < A mutation. Black dots indicate individuals heterozygous for the ABCC9 variant. Gray triangle represents a fetus affected by probable thanatophoric
dysplasia and terminated pregnancy. b Musculoskeletal features in AIMS patients. (1) Lumbar lordosis in patient 1–4 at age 4; (2) lumbar lordosis, thin
habitus in patient 1–2 at age 10; (3) thoracolumbar scoliosis in patient 2–2 at age 28. c Facial features with prominent orbital ridges, hypotelorism, thin
upper lip, ﬂat midface in several of the patients. (1) Family 1. Upper left: patient 1–1 at age 20. Upper right: patient 1–2 at age 16. Lower left: patient 1–3 at age
11. Lower right: patient 1–4 at age 10; (2) proﬁle of patient 1–2 at age 10; (3) proﬁle of patient 1–1 at age 15; (4) patient 2–2 at age 28; (5) patient 2–1 at age
32. d Cerebral MRI of AIMS patients. (1) Magnetic resonance imaging (MRI) of the brain of patient 2–1. T2-weighted ﬂuid-attenuated inversion recovery
(FLAIR), coronal section shows widespread white matter hyperintensities. (2) MRI of the brain of patient 1–1. T2-weighted FLAIR, axial section shows
juxtacortical white matter hyperintensities

the anterior horn of the left ventricle. He regained the same
psychomotor level as before. Weight increased after that episode
and is currently > 97.5 percentile. Neuropsychological testing at
age 9 resulted in a diagnosis of mild intellectual disability.
Obstructive sleep apnea, probably related to being overweight, a

large tongue and hanging soft palate were diagnosed at age 11,
and operative treatment was recommended. Mild bilateral highfrequency hearing loss was found at age 11.
Individual II.3 was a female fetus, conceived inbetween patients
1–2 and 1–3. The parents elected to terminate pregnancy in
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Table 1 General clinical features and dysmorphology of AIMS patients
Patient
Age/sex
Cognitive function
Hypotonia in childhood
Fatigability
Hearing

Sleep aponoea
Psychiatry
Skeletal

Growth

Skin

Dysmorphology
Prominent
supraorbital ridges
Hypotelorism
Broad nasal tip
Dental malocclusion
Flat face
Thin upper lip vermillion
Macrodontia upper
central incisors
Food intolerance/
allergies

1–1
21/female
Mild ID
+
+
Very mild
sensorineural
hearing loss
NA
Anxiety
Lumbal lordosis

1–2
17/male
Mild ID
+
+
N

1–3
13/male
Mild ID
+
+
High-freq mild
hearing loss bilat

1–4
11/male
Mild ID
+
+
High-freq mild
hearing loss bilat

2–1
33/male
Mild ID
+
+
N

2–2
29/female
Moderate ID
+
+
N

NA
Anxiety
Lumbal lordosis

NA
NA
Lumbal lordosis

+
NA
Lumbal lordosis

+
Anxiety
Normal

L:2.5-10p
W:2.5 -10p
OFC:10p
Marmoration

L:10p
W: < 2.5p
OFC:2.5-10p
Marmoration

L:25p
W: < 2.5p
OFC:10p
Marmoration

L:10p
W:97,5p
OFC:50p
Marmoration

L: < 2.5p (162 cm)
OFC:25p
W: > 97.5p
Marmoration
Depigmented
patches
Atopic dermatitis

NA
Anxiety
Congenital hip
dislocation
Scoliosis
Elbow extension
deﬁcit
L: < 2.5p (147 cm)
OFC < 2.5p
W: > 97.5p
Marmoration
Depigmented
patches
Atopic dermatitis
Telangiectasia
left cheek
1 cafe au lait patch

+

+

+

+

+

+

−
+
+
+
+
−

+
+
+
+
+
+

−
−
+
+
+
+, widely spaced

+
−
+
+
+
+, widely spaced

+
+
−
+
+
−

−
+
−
−
+
+

Milk protein
intolerance

Lactose
intolerance

N

Milk protein
intolerance

Food allergies,
anaphylaxia

Food allergies

ID intellectual disability, L length, N normal, NA not assessed, OFC occipitofrontal circumference, W weight

pregnancy week 21, due to suspected thanatophoric dysplasia
with micromelia and a narrow thorax.
Family 2. Patient 2–1 is the ﬁrst child of healthy parents. Pregnancy and birth were unremarkable. Delayed psychomotor
development and muscular hypotonia were noted in toddler
years. Due to similar ﬁndings in him and his sister, with a few
depigmented skin patches and white matter lesions on cerebral
computed tomography scan, a diagnosis of tuberous sclerosis
(TS) was suggested, but later abandoned. The MRI pattern is not
the same as in TS. Neither sibling has experienced epileptic seizures. Feeding was difﬁcult in childhood, with low body weight,
but he gained weight in adulthood, and is now overweight, with
short stature. Severe atopic eczema is currently managed by
cyclosporine, and he has multiple food allergies.
Recent neuropsychological testing led to a diagnosis of mild
intellectual disability. He has been medicated for anxiety with a
selective serotonin reuptake inhibitor for the last few years. He
reports frequent dizziness attacks. Cardiac ultrasound at age 33
revealed biventricular systolic dysfunction, moderate left ventricle
dysfunction, left ventricle ejection fraction (EF) of 35–40%, and
raised NT-proBNP. Left ventricle diameter was within the normal
range, although, cardiac MRI shows left ventricle dilatation,
without obvious pathology of the myocardium—compatible with
early-stage dilated cardiomyopathy. Treatment with an ACE4

antagonist and a beta-blocker was started. Hypertension was
diagnosed before treatment initiation. A cardiac ultrasound in
teenage years was normal. Cerebral MRIs at ages 16 and
33 showed widespread conﬂuent white matter signal changes,
described as similar to leucodystrophy. Lesions have increased
signiﬁcantly since the ﬁrst investigation. MR angiography is
normal, with normal cerebral vasculature calibers. Point lesions
are found in the basal ganglia, pons, and white matter,
representing possible mineral depositions. He lives in a sheltered
home with daily help and supervision. He attends a sheltered
work program, but is easily exhausted, and needs rest during the
day. He is cheerful and social. Muscle strength is normal.
Patient 2–2 is the younger sister of 2–1. Pregnancy and birth
were unremarkable. She was treated for congenital hip dysplasia.
Psychomotor development was delayed. Cerebral MRI in childhood showed periventricular white matter changes, and a
diagnosis of tuberous sclerosis was considered (see above).
Hypotonia, reduced muscle strength, and exhaustibility are
reported since childhood. She has short stature and microcephaly.
She had a thin build in childhood, but is now overweight. Recent
neuropsychological testing indicates mild-to-moderate intellectual disability. She lives in her own ﬂat with assistance. She has
anxiety and has been followed by a local outpatient psychiatry
service. Cardiac ultrasound at age 29 revealed biventricular
systolic dysfunction, mildly reduced left ventricle ejection fraction
(EF) of 48%, and a hypokinetic left ventricle with normal
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Table 2 Neurological, electrophysiological, and cardiac features of AIMS patients
Patient
1–1
Neurological examination
Cranial nerves
Nystagmus
Convergent
strabismus
Muscle strengtha
Hand grip
N
Truncal muscle
−
weakness
Proximal
N
upper limb
Proximal
4
lower limb
Achilles
−
contractures
Hyperreﬂexia
Patella: brisk
(+++)
Achilles:
subclonus
Balance
Moderate–severe
(MiniBESTest)
difﬁculties
Score 16/28
6 -min walk test
Reduced (mean
512.5 m)
Ref: 765 m
Electrophysiology
EMG
N
NCV
N
Repetitive nerve
N
stimulation
EEG
N
Muscle biopsy
NA

Cerebral MRI

Small subcortical
frontal
hyperintensities
MRS: N

Cardiac examination
Cardiac
N
ultrasound

Blood
122/83
pressure (mmHg)

1–2

1–3

1–4

2–1

2–2

Intermittent
heterotropia

N

Bilateral intermittent
esotropia

N

N

4
+

4+
−

4
−

N
−

4
+

N

N

4

N

4

4

N

4

N

4

+

+

+

−

+ (unilateral)

Brachioradialis/
triceps/achilles
brisk ( + + + )

N

N

Patella, achilles:
subclonus

Patella, achilles:
subclonus

Moderate
difﬁculties
Score 20/28
Reduced (mean
485.2 m)
Ref: 725.8 m

Moderate
difﬁculties
Score 18/28
Reduced (mean
467.5 m)
Ref: 697.8 m

Moderate difﬁculties
Score 21/28.

Moderate difﬁculties
Score 18/28

Reduced (mean
428.5 m)
Ref: 672.8 m

Reduced (mean
507.5 m)
Ref: 625 m

Moderate–severe
difﬁculties
Score 14/28
Reduced (mean
418.5 m)
Ref: 668.7 m

N
N
N

N
N
N

N
N
N

N (slight polyfasia)
N
N

N
N
N

NA
Caliber changes,
mitochondrial
aggregations.
Discrete
periventricular
white matter
hyperintensities
(posterior horns)

NA
NA

N
NA

NA
NA

N
NA

White matter
hyperintensities,
centrum
semiovale

Periventricular white
matter hyperintensities
anterior horn of left
lateral ventricle

Widespread white
matter
hyperintensities,
periventricular and
Centrum semiovale
MRA: N

White matter
periventricular
hyperintensities
MRA: N

N

N

N

Mild biventricular
systolic
dysfunction

116/74

106/78

117/69

Biventricular systolic
dysfunction, cardiac
failure, dilated
ventricles
(cardiac MRI)
138/98

118/81

EEG electroencephalogram, EMG electromyography, miniBESTest mini balance evaluation system test, MRA magnetic resonance angiography, MRI magnetic resonance imaging, MRS magnetic resonance
spectroscopy, NCV nerve conduction velocity, N normal, NA not assessed, Ref reference distance
aMuscle strength grading (0–5): 0 = paresis 4 = 50% strength reduction, 4 + = 25% strength reduction 5 = normal

diameter. ProBNP is normal and there are no clinical signs of
cardiac failure at this time. Cerebral MRI performed recently
shows an increase in periventricular white matter signal changes
compared with the last MRI at age 13. MR angiography of
cerebral vessels is normal.
Individual II-2 is the mother of patients 2–1 and 2–2. Recent
cardiac ultrasound, ECG and bicycle stress echocardiogram were
normal at age 51.
Individual II-3 is the younger sister of patients 2–1 and 2–2.
She is healthy, and is the mother of two healthy children. Recent
cardiac ultrasound, ECG, and bicycle stress echocardiogram were
normal at age 25.
Identiﬁcation of a splice site mutation in ABCC9. We performed sequencing of one affected individual from each family

(patients 1–2 and 2–1), plus their respective healthy parents,
using a targeted panel of > 4800 disease-associated genes. The
samples were analyzed for recessive variants (homozygous and
compound heterozygous) and non-Mendelian inheritance. The
two trios were analyzed independently, and from a total of
~10,000 variants in each of the families, the homozygous variant
ABCC9 c.1320 + 1 G > A was the only remaining causal candidate after ﬁltering against quality, region of interest, coding
effect, minor allele frequency, and manual review of ~20 variants
in each of the two families. Next-generation sequencing (NGS)
and subsequent Sanger sequencing revealed that all six patients
were homozygous for ABCC9 c.1320 + 1 G > A. Analysis of DNA
from the four parents and one unaffected sibling from family
2 showed that they were each heterozygous for the same
mutation.
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To exclude distant relatedness between the two families and
thus exclude the possibility of the presence of more shared rare
variants with an effect on protein function, we performed wholegenome sequencing on one affected individual from each family
(patients 1–2 and 2–1), and determined a kinship coefﬁcient of
0.0403. A kinship coefﬁcient of ~0.05 is expected for unrelated
samples, conﬁrming non-relatedness between our families.
Since the original NGS analysis was performed on a gene panel,
we analyzed the WGS data sets for candidate causal recessive and
dominant variants. The focus of the analysis was the identiﬁcation
of shared variants or different variants in shared genes with possible
damaging, but not identical variants leading to the same clinical
phenotype, among the two cases. After the initial analysis, 67 shared
variants were identiﬁed, of which 66 were heterozygous and 1 was
homozygous (Supplementary Table 2). The single homozygous
variant remaining after the ﬁltering was the above variant in
ABCC9:NC_000012.11:g.22063090 C > T; NM_020297.2:c.1320 +
1 G > A (Supplementary Fig. 2). This variant lies in a shared
homozygous block of 3.8 MB (chr12:18.326.590-22.176.010 hg19).
Notably, gene interactions with the homozygous ABCC9 c.1320 + 1
G > A variant cannot be excluded as participating in the syndrome.
A list of all shared variants including allele frequencies is provided
in Supplementary Table 2. For a dominant mode of inheritance, we
observed that, in 842 genes, one or more variants pass the ﬁltering
criteria in both cases. Again, the ABCC9 variant was the only
variant seen in homozygous state in both samples (Supplementary
Fig. 3). Compound heterozygous gene candidate analysis identiﬁed
seven genes with two or more variants shared between the two
cases. None of these genes are likely to contribute to the phenotype
(Supplementary Fig. 4). Thus, after gene panel and WGS, we
identiﬁed the homozygous ABCC9 c.1320 + 1 G > A variant as
the most likely causal variant. The variant is reported at very low
allele frequency in the heterozygous state in the European
population (Finnish: 3/6586; European: (Non-Finnish) 4/66386,
Exac, June 2018). According to gnomAD, the variant is reported at
surprisingly high frequency in heterozygous state in the Finnish
population with an allele frequency of 0.0007 (18/24850). It is less
common in non-Finnish Europeans (5/128232, allele frequency
0.00004) and absent in Asian or African populations (May 2019).
Considering the probable Finnish ancestry of all patients, the
syndrome might be more prevalent in the Finnish population than
others. The homozygous state is absent in gnomAD.
The ABCC9 c.1320 + 1 G > A variant is predicted to disrupt a
splice donor site of exon 8 (Fig. 2a). To study the effect of the
mutation, we performed cDNA analysis on ﬁbroblasts from
members of both families (Fig. 2b). Sequence analysis of the
homozygous cDNA samples revealed that the sequence variant
caused an in-frame deletion of exon 8 (r.1165_1320del) in SUR2
cDNA, and predicts a 52 amino acid (p.Ala389_Gln440del)
deletion within the SUR2 protein. Thus, all patients are
homozygous for a splice variant in ABCC9 which results in an
in-frame deletion.
The effect of exon 8 deletion on KATP channel function.
Deletion of exon 8 is predicted to disrupt multiple transmembrane helices in SUR2 and thus have a profound effect on
structure and function (Fig. 3a). We deleted exon 8 in SUR2
cDNA (SUR2AΔ8) and performed expression analyses on
Cosm6 cells transiently transfected with Kir6.2 alongside either
Flag-tagged SUR2A-WT or SUR2AΔ8. Western blot of wholecell lysates shows that exon 8 deletion results in a ~50% decrease
in SUR2 protein expression (Fig. 3b). We used a radioactive
rubidium (86Rb+) efﬂux assay to determine effects on KATP
channel function. Cells expressing SUR2A-WT with Kir6.2
exhibited robust rubidium efﬂux rates when KATP channels were
6

activated by metabolic inhibition (Fig. 3c). In contrast, cells
expressing Kir6.2/SUR2AΔ8 showed no rubidium efﬂux above
the background levels observed in GFP-transfected cells. When
Kir6.2 was co-expressed with a heteromeric 1:1 ratio of SUR2AWT and SUR2AΔ8, KATP-dependent efﬂux rate was similar to
WT rates, indicating that SUR2AΔ8 has no marked dominantnegative effect on functional KATP expression. The effect of the
exon 8 deletion in SUR2B was also determined and, again, no
signiﬁcant efﬂux was observed in cells expressing SUR2BΔ8
(Fig. 3d).
A complete absence of functional KATP channels was observed
in inside–out patch clamp recordings from cells co-transfected
with Kir6.2/SUR2AΔ8, in contrast to robust expression in cells
transfected with SUR2A-WT or a 1:1 mix of SUR2A-WT and
SUR2AΔ8 (Fig. 3e, f). Therefore, homomeric deletion of exon 8
results in a signiﬁcant decrease in protein expression and
complete loss of KATP channel function. The decrease in
functional expression of SUR2Δ8 containing channels may arise
due to either the absence of surface-expressed channels or the
expression of nonfunctional channels, which requires more
detailed study for elucidation. Co-expression of SUR2A-WT
and SUR2AΔ8 did not affect channel regulation by ATP or
pharmacological activation by pinacidil, suggesting that in the
heterozygous context, the c.1320 + 1 G > A mutation is without
signiﬁcant effect (Fig. 3g; Supplementary Fig. 5).
Fatigability and cardiac dysfunction in SUR2-STOP mice. To
model the effects of SUR2 LoF in vivo, we used a mouse line in
which a frameshift mutation, resulting in a premature stop codon
at position Y1148 (SUR2-STOP), was introduced using CRISPR/
Cas9 (Fig. 4a). Inside–out patch clamp recordings from ventricular myocytes and aortic smooth muscle cells showed that
functional KATP channels were essentially absent in homozygous
SUR2-STOP mice (Fig. 4b, c; Supplementary Fig. 6), thus the
SUR2-STOP mice recapitulate the key functional channel consequences of the exon 8 deletion.
SUR2-STOP mice and WT littermate controls were evaluated
on a multiple-trial inverted screen test to assess strength and
fatigability. SUR2-STOP and WT mice performed comparably in
the ﬁrst trial, suggesting no signiﬁcant initial deﬁcits in strength
per se. However, in subsequent repeated trials, SUR2-STOP mice
exhibited clear decreases in performance, whereas WT mice
performance remained high (Fig. 4d). Signiﬁcant genotype effects
were observed, as well as genotype x trial and genotype x session
interactions (Supplementary Table 3). These ﬁndings indicate
that SUR2-STOP mice exhibited signiﬁcant performance deﬁcits,
dependent on the speciﬁc session and trial. The total time the
mice remained inverted across the six trials was calculated, and a
signiﬁcant decrease in performance was observed in SUR2-STOP
mice (Fig. 4e). Thus, global loss of SUR2 results in decreased
physical performance, suggestive of increased fatigability, which
may be related to the clinically observed myopathy.
Echocardiographic assessment revealed that left ventricle
fractional shortening was signiﬁcantly decreased in SUR2-STOP
mice (Fig. 4f, g), consistent with the ﬁndings in older AIMS
patients, and in previously reported SUR2-deﬁcient mice22. A
small, but statistically signiﬁcant increase in left ventricular
internal dimension in diastole (normalized to body length) was
observed in SUR2-STOP mice, also mirroring the mild dilatation
observed our eldest patient (patient 2–1), and the dilated
cardiomyopathy previously associated with SUR2 mutations18.
Blood pressure was signiﬁcantly increased in SUR2-STOP mice
(Supplementary Fig. 6C, D), consistent with the known role of
SUR2-containing vascular smooth muscle KATP channels in the
regulation of vascular tone23.
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Fig. 2 Molecular analysis in AIMS patients. a Genomic organization of the ABCC9 gene: (1) basic genomic structure of ABCC9 includes at least 39 potential
exons, excluding untranslated regions (UTRs). The c.1320 + 1 G > A mutation predicted to disrupt the splice donor site of exon 8 is indicated by a red
arrow. Scale bar, 5000 bp. (2) The mutation impacts both the SUR2A and SUR2B splice forms, which differ only in the last exon. Affected exon 8 in
patients is marked in red. Odd-numbered exons are presented as black boxes, even-numbered exons as gray boxes. b Analysis of the effect of the mutation
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Absence of cognitive or behavioral defects in SUR2-STOP
mice. SUR2-STOP and WT mice were evaluated on a battery of
cognitive and behavioral tests. During a 1-h locomotor activity
test, SUR2-STOP mice displayed trends toward decreased total
ambulations (whole-body movements) and vertical rearing frequency, and increased rest time, but there were no signiﬁcant
overall genotype effects (Fig. 5a–c). No differences were observed
in the distance traveled in the center or peripheral zones of the
test ﬁeld, indices of emotionality in mice (Fig. 5d, e). In addition,
neither signiﬁcant effects were found in a battery of sensorimotor
measures designed to assess balance, coordination, strength, and
speed of movement (ledge test, platform test, pole test, inclined
screen test, Fig. 5f–i) nor in tests of spatial learning and memory,
evaluated using a Morris water maze (Fig. 5j–l). Finally, an elevated plus maze was used to assess anxiety-like behaviors, which
involves quantifying the reluctance of mice to move from the
“protected areas” of the enclosed arms to open arms. No signiﬁcant differences were observed between genotypes in terms of
distance traveled, time spent or entries made into the open arms,
or total distance traveled throughout the entire maze (Fig. 5m–p).
Collectively, the behavioral ﬁndings suggest that the SUR2-STOP
mice do not exhibit marked deﬁcits in learning and memory nor
show any obvious anxiety-like behaviors.
Decreased motility in SUR2-STOP zebraﬁsh. Assessment of a
SUR2-STOP zebraﬁsh model (Fig. 6a, b) also demonstrated clear
phenotypic overlap with the clinical syndrome and mouse model.
cDNA was analyzed by qPCR, to assess the effect of the S985
truncation, introduced via CRISPR/Cas9, on abcc9 mRNA
expression in SUR2-STOP zebraﬁsh larvae. This revealed ~fourfold abcc9 mRNA decrease in mutant ﬁsh compared with wildtype controls (Fig. 6c), consistent with aberrant mRNA being
eliminated by nonsense mediated decay. Inside–out patch clamp
recordings revealed the complete absence of functional KATP

channels in ventricular myocytes from SUR2-STOP zebraﬁsh
(Fig. 6d). Hence, the zebraﬁsh model also recapitulates the key
channel consequences of the exon 8 deletion.
Consistent with hypotelorism observed in multiple AIMS
patients, signiﬁcantly decreased interorbital distance, normalized
to overall larval body length, was observed in SUR2-STOP
zebraﬁsh (Fig. 6d, e). In contrast, no signiﬁcant difference was
observed between the inter-eye distance in WT and SUR2-STOP
mice. Visual inspection of SUR2-STOP zebraﬁsh revealed no
other striking dysmorphic features (Fig. 6b). We used a
behavioral tracking system to quantify locomotor activity in
zebraﬁsh larvae (Fig. 6f). SUR2-STOP larvae displayed signiﬁcantly decreased spontaneous total movement and decreased total
swimming distance compared with control larvae (Fig. 6g, h).
Despite shorter swimming distances, SUR2-STOP embryos move
for a similar period of time as WT ﬁsh (Fig. 6i). Analysis of the
duration of high-speed movements revealed a signiﬁcant decrease
in SUR2-STOP larvae (Fig. 6j). Notably, SUR2-STOP embryos
hatched normally from their chorion, a process that also requires
muscle contraction.
Cardiac abnormalities in SUR2-STOP zebraﬁsh. We performed
high-speed video imaging24 of the hearts of wild-type and SUR2STOP larvae to examine cardiac function (Fig. 7a; Supplementary
Movies 1, 2). Analysis revealed systolic dysfunction—resembling the
cardiac phenotype in older patients. Both fractional shortening (FS)
and ejection fraction (EF) are signiﬁcantly reduced in SUR2-STOP
mutants (FS: 29%, EF: 25%) (Fig. 7b, c). Consequently, cardiac
output is dramatically lower (28%) (Fig. 7d) due to equivalently
reduced stroke volume (Supplementary Fig. 7A). Supplementary
Fig. 8 illustrates the assessment of ventricular contractility via highspeed video microscopy in zebraﬁsh embryos. Ventricular enddiastolic volume (VEDV) and end-systolic volume (VESV) were
unchanged in SUR2-STOP larvae (Fig. 7e).
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Blood ﬂow velocity of WT and SUR2-STOP larvae was
assessed by high-speed video imaging of the cardinal vein. An
increased velocity of red blood cells in SUR2-STOP ﬁsh (Fig. 7f)
can be associated with high blood pressure found in SUR2STOP mice.
No cardiac abnormalities were observed in larvae heterozygous
for the SUR2-STOP mutation (Supplementary Fig. 9).
Adult zebraﬁsh hearts were analyzed after sectioning and H&E
staining (Fig. 7g). For assessment of ventricular size, tissue
sections revealing the largest chamber area were selected. In ﬁve
out of six SUR2-STOP ﬁsh, ventricular area was strikingly
enlarged with abnormal morphology compared with control
siblings. The atrial area shows similar morphology (Fig. 7f;
Supplementary Fig. 10). We stained cryosections of WT and
8

SUR2-STOP hearts with Acid Fuchsin Orange G (AFOG), which
labels myocardium orange, collagen blue, and ﬁbrin red. This
revealed no visible ﬁbrosis in SUR2-STOP hearts (Supplementary
Fig. 11). TUNEL (TdT-mediated nick end labeling) analysis
revealed very few apoptotic cells in WT hearts, while a sizable
number of cells were TUNEL-positive in both cardiac chambers
of SUR2-STOP ﬁsh (Fig. 7h). Myoﬁber structure in SUR2-STOP
hearts is not different from WT as determined by immunohistochemistry staining for tropomyosin (Supplementary Fig. 12).
Discussion
The major clinical features observed in our patients consist of
delayed psychomotor development with intellectual disability,
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provided as a Source Data ﬁle

anxiety, muscle weakness and fatigability, and some shared dysmorphic features. Cerebral MRI revealed white matter abnormalities in all subjects. Cardiac systolic dysfunction is found in the
two oldest, possibly as an early stage of dilated cardiomyopathy.
All patients were found to be homozygous for a previously
unreported splice site mutation in ABCC9 (c.1320 + 1 G > A),
while unaffected parents are healthy heterozygous carriers of the
variant (Fig. 2). No other shared recessive mutations were

identiﬁed in the affected individuals using either next-generation
gene panel analysis or whole-genome sequencing.
We show that this splice site mutation leads to the complete inframe exclusion of exon 8 (SUR2Δ8) and consequent deletion of
52 amino acids within the TMD1 domain of the resultant SUR2
protein (Fig. 3). SUR2 is a regulatory subunit of KATP channels
expressed in various tissues, including striated and smooth
muscle3–5. Deletion of exon 8 results in complete loss of
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functional channel activity in recombinant SUR2/Kir6.2 KATP
channels, indicating that AIMS represents the human consequence of loss of SUR2 (Fig. 3). We show that key features of
myopathy and cardiac dysfunction in AIMS are recapitulated in
novel SUR2-STOP mouse (Figs. 4, 5) and zebraﬁsh models
(Figs. 6, 7). The animal models used in this study do not recapitulate the genetic defect identiﬁed in the AIMS patients, but
were chosen as the functional effects of the frameshift mutations
introduced into SUR2-STOP mice and ﬁsh mirror the functional
effect of the SUR2Δ8 mutation. Future studies of CRISPR/Cas9
genome edited animal models in which human-disease-associated
10

AIMS mutations are introduced may provide further insights into
the severity and variety of phenotypes arising from speciﬁc
mutations.
How loss of SUR2-dependent KATP channel function may
result in the complex pathophysiology observed in AIMS is
discussed below.
Facial features: Affected individuals from the two families share
some similar facial features, including prominent supraorbital
ridges, ﬂat face, and thin upper lip vermilion, as well as macrodontia and/or widely spaced upper central incisors and dental
malocclusion. Since the affected individuals are from two
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siblingships, more patient observations will be necessary in order
to establish whether these facial features are consistent. Some
of the individuals have hypotelorism, consistent with signiﬁcantly
decreased intraorbital distance found in SUR2-STOP zebraﬁsh
(Fig. 6f, g). This combination of facial features is markedly
different from the acromegaloid facial features that characterize
Cantú Syndrome and the associated conditions within the
same spectrum: Acromegaloid Facial Features (AFF [MIM:
102150])25 and hypertrichosis acromegaloid facial features disorder (HAFF)26, which all arise from GoF mutations in ABCC9.
None of our patients have hypertrichosis, unlike Cantú syndrome
patients. Therefore, Cantú syndrome and AIMS, arising from
opposing molecular mechanisms, are both dysmorphologically
and mechanistically distinct.
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Neuromuscular manifestations: All patients report fatigability,
present with generalized hypotonia, and muscle strength is below
normal in all but one. Lumbar lordosis is found in all but one,
and scoliosis in one. The miniBEST test shows moderate to
severe deﬁcits in balance in all patients, and walking distance in
the 6-min walk test is reduced in all individuals. S-CK, B-lactate,
nerve conduction velocities, and electromyography, including
repetitive nerve stimulation, are normal in all individuals, except
for discrete myopathic discharges in patient 2–2. In skeletal
muscle, KATP channels are typically closed at rest but open in
response to metabolic stress or fatigue27. Channel activation
results in action potential shortening and stabilization of the
resting membrane potential during the development of fatigue,
which serves to reduce intracellular calcium, decrease resting
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Fig. 6 Hypotolerism and decreased locomotor behavior in SUR2-STOP zebraﬁsh larvae. a The c.2944_2957del13 indel in abcc9 and consequent frameshift
premature stop codon following S984 (p.S985Stop) and schematic of SUR2 with the site of the introduced S985Stop mutation in TM12 indicated,
downstream region in blue. b Representative images illustrating the morphology of 5 dpf wild-type and SUR2-STOP mutants as seen from a left lateral
(top) and dorsal view (bottom). Scale bars, 1 mm. c Quantitative RT-PCR to assess abcc9 expression in pools of 60 WT (three pools) and SUR2-STOP (four
pools) embryos. d Representative current traces from inside–out patch clamp recordings from ventricular myocytes of WT (black; ﬁve patches) or SUR2STOP (blue; six patches) zebraﬁsh (−50 mV holding potential, ATP applied as indicated). e KATP channel currents from excised patches from zebraﬁsh
ventricular myocytes. The data from ﬁve patches (WT), and six patches (SUR2-STOP) from ≥ 3 zebraﬁsh. f, g To assess hypotelorism, the distance
between the convex tips of the eyes was measured and normalized to body length (WT, n = 8; HOM, n = 10). Scale bars, 200 μm. h Examples of
movement traces shown in red, green, and black representing high-speed, intermediate, and slow movements, respectively. i–l Five-minute video
recordings (n = 62 larvae per genotype) of 5 dpf homozygous SUR2-STOP ﬁsh and wild-type controls were analyzed for total amount of movement i, total
swimming distance (TSD) j, total swimming duration k, and duration of high-speed movements l and compared with respective wild-type larvae. The data
on the y-axis refer to the respective average value per 30-s (s) intervals. The data from four independent experiments (16 larvae per experiment) *p ≤ 0.05;
**p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001 (two-tailed unpaired Student’s t test or Mann–Whitney U test). The black horizontal bar indicates the mean value
for each condition. Sample size, WT, n = 3; SUR2-STOP, n = 4 in c; WT, n = 5; SUR2-STOP, n = 5 in e; WT, n = 8; SUR2-STOP, n = 10 in g; WT, n = 62;
SUR2-STOP, n = 62 in i–l. The data from individual experiments shown as dots alongside mean ± SEM. Source data are provided as a Source Data ﬁle

tension and protect myocytes from damage. Therefore, loss of
KATP function might be expected to result in failure to recover
from fatigue, myoﬁber degeneration, and excessive calcium
inﬂux, as reﬂected in the inverted screen tests in the mice. In
addition, lower limb hyperreﬂexia was observed in the four
oldest individuals, which might be caused by the white matter
abnormalities and decreased inhibition or increased activation of
upper motor neurons.
Although the expression pattern of Kir6.2 is not identical to
that of SUR2, it is notable that previous studies of Kir6.2-null
mice, as well as mice in which an internal deletion in SUR2 was
engineered (resulting in loss of full length SUR2 but persistent
expression of a mitochondria-limited short form), have reported
that the consequent decrease of myocyte KATP activity results in
impaired exercise capacity and response, and myoﬁber
damage22,28. Only relatively minor histological abnormalities
were observed in a single-skeletal muscle biopsy from patient 1–2.
This is consistent with previous reports which showed that SUR2
knockout mice only exhibit signiﬁcant histological abnormalities
when subjected to signiﬁcant and chronic exercise29. Here, we
show that novel mouse and zebraﬁsh models, in which CRISPR/
Cas9 was used to introduce frameshift mutations resulting in
premature stop codons and nonfunctional subunits, also exhibit
decreased performance. Speciﬁcally, SUR2-STOP mice showed a
diminished ability to hang upside down during the multiple-trial
inverted screen test, suggesting decreased strength resulting from
increased fatigability30,31 (Fig. 4d, e), while SUR2-STOP zebraﬁsh
show decreased total overall movement and swimming speed in
tracking studies (Fig. 6i–l).
Intellectual disability and neurological abnormalities: Neuropsychological testing revealed mild-to-moderate intellectual
disability in all affected individuals, and anxiety was also reported
in several patients. It is not obvious how myocyte KATP dysfunction could explain the intellectual disability or anxiety, and
there are no reports of cognitive impairment in previous SUR2
mutant animal models. Neuronal KATP channels are predominantly formed of Kir6.2 with SUR1 subunits, although
transcripts for all KATP channel subunits have been identiﬁed in
various neuronal populations32 and SUR2 is reportedly expressed
in both central and peripheral neurons33–35, where it has been
implicated in hippocampal sclerosis in aging and amyotrophic
lateral sclerosis33,36–38.
However, recent data demonstrate that SUR2-containing KATP
channels play a critical role in regulation of cerebral vascular
architecture16. In Cantú syndrome, MRI reveals diffusely dilated
and tortuous cerebral blood vessels and white matter changes as
multiple T2 subcortical or scattered hyperintensities. Transient
12

white matter changes suggestive of a reversible posterior encephalopathic syndrome are reported in one patient. Several Cantú
syndrome patients have migraine, and some have epilepsy.
Developmental delay is common, although seeming to improve
with age16. Since KATP channel GoF results in chronic vasodilation and altered neuro–vascular coupling16, it is conceivable that
KATP loss of function may impact the cerebral vasculature in a
way that results in impaired dynamic coupling of blood ﬂow to
match neuronal metabolic demand.
Patient 1-1 has a diagnosis of epilepsy with episodes of
unconsciousness and tonic-clonic seizures, but no deﬁnitive epileptic activity has been demonstrated on EEGs. Patient 1-4
experienced an episode of coma with transient widespread white
and gray matter abnormalities, which is left unexplained. Possibly, these incidents could be caused by focal or generalized circulatory alterations. Interestingly, white matter hyperintensities
are observed in both Cantú syndrome and AIMS. In both cases,
they could result from ischemic events due to dysregulated cerebral blood ﬂow, although the cognitive phenotype seems to be
more deﬁnite in AIMS than in Cantú syndrome. Tests for cognitive deﬁcits and anxiety did not reveal signiﬁcant behavioral
impairments in SUR2-STOP mice (Fig. 5). Additional testing for
speciﬁc deﬁcits (such as an assessment of working memory, fear
conditioning, or other nonspatial forms of learning and memory)
would be necessary to more fully characterize the behavioral
phenotype of the SUR2-STOP mice. Notably, mild cognitive
impairment, as seen in humans, can be difﬁcult to recognize in
animals39. Whole-genome sequencing and copy number analysis
did not identify other causes of intellectual disability in our
patients.
Cardiovascular manifestations: While the younger patients
(aged 11–21) displayed no clear cardiovascular abnormalities, the
two oldest patients display cardiac biventricular systolic dysfunction, with only slightly decreased ejection fractions. No
clinical signs of heart failure were observed in patient 2–2, but
decreased ejection fraction and heart failure was observed in her
brother, patient 2–1. Cardiac MRI in patient 2–1 showed dilated
ventricles, and together with other clinical ﬁndings this may
suggest early stages of dilated cardiomyopathy. In a previous
study by Bienegraber et al., two individuals with dilated cardiomyopathy (DCM) were found to have heterozygous, LoF, missense mutations in exon 38 of ABCC9, an exon only included in
the SUR2A splice variant, and not in SUR2B18. In that case, KATP
LoF would be expected in cardiomyocytes and skeletal muscle but
not smooth muscle, where SUR2B is expressed. The DCM
patients reported in that study were older than the patients we
report and displayed drastic reductions in ejection fraction (to
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15–23%). This may suggest a progressive cardiomyopathy which
will require longitudinal analysis in AIMS.
In previously reported mouse models, SUR2 knockout resulted
in cardiac hypertrophy with LV dilation and decreased fractional
shortening22,40. Here, we show that SUR2-STOP mice also display decreased fractional shortening and LV dilation (Fig. 4f, g),
while SUR2-STOP zebraﬁsh show marked cardiac enlargement

with reduced ejection fraction and cardiac output (Fig. 7b–d),
again consistent with the observed clinical phenotype in the older
AIMS patients. Signiﬁcant cardiomegaly, with elevated cardiac
output, is observed in Cantú Syndrome. This cardiac remodeling
may arise as a secondary compensation to counter the vasodilatory effect of KATP GoF in vascular smooth muscle cells41,42.
SUR2 LoF, in contrast, would be expected to increase vascular
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Fig. 7 Systolic dysfunction and enlarged heart size in SUR2-STOP zebraﬁsh. a Box designates imaged area to assess cardiac function. The ventricular area
of the heart is highlighted, with the long axis and short axis of the ventricle indicated by dashed lines. b–e Quantiﬁcation of cardiac function using individual
characteristic confocal sections from a time series of the embryonic cardiac cycle at 5 dpf. f Tracking of individual red blood cells (RBCs) measuring
cardinal vein blood ﬂow velocity. RBCs were tracked for ten frames using ImageJ (NIH) and the plugin MTrackJ68. One representative image of each
genotype is shown. Black arrow indicates the direction of RBC movement. g Heart histology of adult SUR2-STOP mutants and respective siblings after H&E
staining. Exemplary depiction of 2 WT and 2 SUR2-STOP hearts. For assessment of ventricular chamber size, tissue sections showing the largest
ventricular area were selected. h TUNEL assay on adult hearts to detect apoptotic cells (white arrowheads) in WT and SUR2-STOP ﬁsh. Heart chambers
are indicated by white dashed line. Nuclei are stained with DAPI. All experiments were performed comparing SUR2-STOP and its WT siblings. For all
graphs, signiﬁcance was determined by two-tailed unpaired Student’s t test or Mann–Whitney two-tailed U test. Asterisks indicate statistical signiﬁcance
(*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001). The black horizontal bar indicates the mean value for each condition. Sample size, WT, n = 20; SUR2STOP, n = 20 in b–e; WT, n = 14; SUR2-STOP, n = 21 in f; WT, n = 6; SUR2-STOP, n = 6 in g and h. Scale bars, 1 mm and 50 μm in a; 10 μm in f, 500 μm in
g; 100 μm (overview) and 50 μm (close up) in h. All embryos analyzed originated from group matings of adult zebraﬁsh. a atrium, ba bulbous arteriosus, v
ventricle. The data from individual experiments shown as dots alongside mean ± SEM. Source data are provided as a Source Data ﬁle

contractility and blood pressure. However, blood pressure was
normal in AIMS patients, except for elevated systemic pressures
in the oldest patient. SUR2 and Kir6.1-null mice are
hypertensive43,44, which is again a feature of the SUR2-STOP
mice, but in humans, effects on blood pressure may be more
subtle and subject to tighter regulation through homeostatic
feedback, or perhaps not yet manifesting in our still relatively
young patients.
Other features: Mild hearing loss was found in 3/6 patients.
This is not straightforward to explain, as there is no known
function for SUR2 in auditory neurons. One explanation might be
altered vascular tone and ischemic stress of these neurons. Strabismus and myopia were found in several individuals while one
also displayed nystagmus. Sensory assessment was not performed
in our animal models but should be the subject of future study.
Feeding difﬁculties in childhood were reported in all individuals.
KATP channels are expressed in gastrointestinal smooth muscle45,
and thus LoF may affect GI contractility and motility. The two
patients in family 2 have short stature and microcephaly. In
Cantú syndrome, there is a range of skeletal manifestations. Our
patients are not thoroughly evaluated radiologically, but do not
display obvious skeletal changes, except for scoliosis, congenital
hip dysplasia, and elbow extension deﬁcits in patient 2–2. Lastly,
patient 1–1 presents with hyperprolactinemia lacking pituitary
adenomas. Interestingly, pituitary adenomas and elevated levels
of prolactin are recently reported in a family with Cantú
syndrome46.
Disease progression: As discussed above, the two oldest
patients exhibit decreased myocardial contractility, which may
reﬂect the onset of a progressive cardiomyopathy, and hypertension is found in the oldest patient. It will be important to
chronicle the long-term effects of KATP LoF in all the patients to
elucidate the natural history of AIMS, which may also be
informed by longitudinal studies in the animal models presented
here. White matter hyperintensities were found to have increased
with age in the two oldest patients, where MRIs have been
repeated.
Heterozygous carriers: Lack of phenotype in the healthy heterozygous carriers of the ABCC9 c.1320 + 1 G > A variant is
consistent with functional studies of recombinant KATP channels
reported here, which show that SUR2Δ8 subunits do not exert
obvious dominant-negative effects in heterozygous expression
with WT subunits. Indeed, essentially normal Rb ﬂuxes in this
case may reﬂect a rescue by WT subunits (Fig. 3c).
Possible additional molecular consequences: In addition to its
canonical role as a regulatory subunit of plasmalemmal KATP
channels, short-form variants of SUR2 have been identiﬁed in the
mitochondria and reported to form functional KATP channels6,
although the role of these truncated channel complexes remain
poorly understood. It is also conceivable that SUR2 proteins play
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additional noncanonical (i.e., non-channel regulatory) roles,
which may or may not be impaired by the exon 8 deletion.
Importantly, the animal models employed here, in which premature stop codons were engineered into ABCC9, are not a bona
ﬁde recapitulation of the human genetics of the AIMS patients,
and accordingly may not reiterate speciﬁc novel consequences of
the truncated SUR2Δ8 protein.
Potential pharmacotherapy: In principle, KATP channel LoF
could be countered using KATP channel activators, such as cromakalin, pinacidil, diazoxide or minoxidil, which are used clinically as vasodilatory agents47. In the case of the AIMS patients
presented here, however, where the exon 8 deletion results in a
complete loss of functional channel expression, these drugs would
likely be ineffective. Interestingly, in each of the myocyte tissues
in which SUR2 is expressed, KATP forms part of an electrical
“brake”, where KATP activation results in membrane potential
hyperpolarization, decreased intracellular calcium, and promotes
myocyte relaxation. Loss of KATP function is therefore expected to
increase intracellular calcium and modulating myocyte calcium
handling might prove beneﬁcial.
In the future, it is expected that AIMS patients will be identiﬁed
with additional mutations in ABCC9. Such mutations may prove
to be autosomal dominant or may exhibit only partial LoF, as is
observed in the analogous pancreatic KATP disorder, congenital
hyperinsulissm (CHI [MIM: 256450]), which arises from
LoF mutations in ABCC848. Depending on the mutational consequence, some CHI patients are responsive to treatment by the
potassium channel opener diazoxide, and KATP-openers may
indeed prove beneﬁcial in some AIMS patients.
Methods
Patients. Four siblings from Family 1 and two siblings from Family 2 (Fig. 1a,
pedigrees) were initially referred for assessment of developmental delay and/or
neuromuscular impairment, and were investigated in a clinical diagnostic setting.
Written informed consent for Next-Generation-Sequencing in both a diagnostic
and research setting was obtained from the patients’ parents. The authors afﬁrm
that human research participants provided informed consent for publication of the
images in Fig. 1b–d. Whole-genome sequencing on patients was approved by the
Medical Ethical Committee of the University Medical Center Utrecht. All study
participants, or their legal guardian, provided informed written consent prior to
publication.
Clinical evaluation by the Neuromuscular Centre team. The clinical diagnostic
evaluation included patient history, a structured neurological examination and
physiotherapist examinations including the mini-Balance Evaluation System Test
(miniBEST)49 and 6-min walk test. The miniBEST is an assessment of dynamic
balance and postural control. There are no normative values for children or people
with intellectual disability, but the test was modiﬁed for our patients. The 6-min
walking test- 6MWT50,51 assesses distance walked over 6 min as a sub-maximal test
of aerobic capacity/endurance. For adults, normative values can be calculated by an
equation developed by Enright and Sherill (1998)50. The calculations are: men:
6MWD = (7.57 × height cm) – (5.02 × age) – (1.76 × weight kg) − 309. Women:
6MWD = (2.11 × height cm) − (2.29 × weight kg) − (5.78 × age) + 667 m)). Normative values for children and adolescents are described by Geiger et al.51.
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Normative values are not given for intellectually disabled people. The neurological
examination comprised the following: cranial nerve examination, motor function
(strength, tempo, tone), deep tendon reﬂexes (biceps, brachioradialis, triceps,
patella, achilles) and plantar reﬂexes, superﬁcial skin sensation, vibration, proprioception, cerebellar function tests, and gait. In addition, the following supplementary electrophysiological investigations were performed: electromyography
(EMG), nerve conduction studies (NCS), repetitive nerve stimulation. All patients
had previously undergone cerebral magnetic resonance imaging (MRI). Blood
samples were analyzed for serum levels of CK and lactate. In addition, all patients
had audiometry, electrocardiograms (ECG), and electrocardiography done.
Illumina TruSight One gene panel analysis. DNA libraries for sequencing of
4813 genes with known associated clinical phenotypes were generated for patients
1–2 and 2–1 (Fig. 1) with their respective parents for trio analyses.
Genomic DNA was extracted from whole blood using MagAttract DNA midi 48
kit (Qiagen, katalognr 951356) on a Biorobot M48 (Qiagen) according to the
manufacturer’s protocol. Sequencing libraries were prepared from 50 ng of gDNA
using the TruSight One Sequencing Panel (Illumina, San Diego, CA, USA)
according to the manufacturer’s instructions, Paired-end 150 bp sequencing was
performed on a MiSeq (Illumina). Desktop Sequencer, targeting a mean region
coverage depth > 100x and > 97% of the region at > 10 × . Analysis of sequencing
data was performed by applying a MiSeq Reporter Enrichment Workﬂow
(v.2.4.60.8) including a Burrows–Wheeler Aligner (v.0.6.1-r104-tpx) and a Genome
Analysis Toolkit (v.1.6-22-g3ec78bd), with the target region deﬁned as the exome
part with ﬂanking 10 bp of 4813 disease-associated genes as deﬁned by Illumina
TruSight One Sequencing panel (http://www.illumina.com/products/trusight-onesequencing-panel.html).
Cartagenia Bench Lab NGS (v.4) was used for variant annotation and
prioritization, considering a recessive inheritance model using Cartagenia
Inheritance analysis with the index patients deﬁned as affected and the parents as
unaffected. The focus of the analysis was to identify potentially damaging
homozygous or compound heterozygous variants inherited in a recessive pattern
from both the parents, or variants showing non-Mendelian inheritance, indicating
a de novo event. Variants were ﬁltered based on quality criteria (LowGQX < 10,
LowVariantFreq < 0.20, LowGQ < 30.00, R8 > 8, SB > -10, LowDP < 20) and their
presence in population frequency databases with a maximum minor allele
frequency of 1 % (ExAC, 1000 genomes, dbSNP. Splice-site analysis was restricted
to 8 intronic bp positions from the nearest intron–exon boundary and 3 exonic bp
positions from the nearest intron–exon boundary. Findings in patients 1–2 and 2–1
were validated by Sanger sequencing. Sanger sequencing for the ABCC9 sequence
variant was performed for both healthy and affected family members.
Whole-genome sequencing. DNA libraries for Illumina sequencing were generated for patients 1–2 and 2–1 using standard protocols (Illumina) from 200 –1 μg
of genomic DNA. The libraries were sequenced with paired-end (2 × 150 bp) runs
using Illumina HiSeq X Ten sequencers with a target depth of 30 × base coverage.
The Illumina data were processed with our in-house developed pipeline v 2.5.1
(https://github.com/UMCUGenetics/IAP) including Genome Analysis Toolkit
(GATK) v3.4-4652 according to the best practices guidelines53. Brieﬂy, sequence
reads were mapped against the human reference genome GRCh37 using
Burrows–Wheeler Aligner v0.7.5a mapping tool54. Sequence reads were marked for
duplicates using Sambamba v0.5.855 and recalibrated per sample using GATK
BaseRecalibrator. Next, GATK Haplotypecaller was used to call SNPs and indels to
create gVCF’s. These gVCF’s were genotyped with GATK. Variants are ﬂagged as
PASS only if they do not meet the following criteria: QD < 2.0, MQ < 40.0, FS >
60.0, HaplotypeScore > 13.0, MQRankSum < -12.5, ReadPosRankSum < -8.0,
snpclusters > = 3 in 35 bp. For indels: QD < 2.0, FS > 200.0, ReadPosRankSum
< -20.0. WGS statistics are provided in Supplementary Table 1.
Full analysis was performed on a merge of the reference coding regions
obtained from Ensembl (v.75) (http://www.ensembl.org/) and UCSC (https://
genome.ucsc.edu/) with ± 100 bp ﬂanks. Cartagenia Bench Lab NGS v.4.3.5 was
used for variant interpretation and prioritization. Variant analyses were made
considering a recessive inheritance model using the Cartagenia cohort analysis tool.
The focus of the analysis was to identify shared variants or shared genes with
possible damaging, but not identical variants, amongst the two cases. Lenient
quality parameters were used to determine high quality variant calls (read depth > 4
reads, ﬁlter:pass, genotype quality > 98). Variants were ﬁltered based on presence in
population frequency databases with a maximum MAF of 1% (ExAC, 1000
genomes, dbSNP, and GoNL). Variants are categorized as LoF (frameshift,
stopgain, startloss, stoploss), nonsynonymous, synonymous, and inframe variants.
Furthermore, splice-site analysis was restricted to 8 intronic bp positions from the
nearest intron–exon boundary and 3 exonic bp positions from the nearest
intron–exon boundary. The Kinship coefﬁcient was calculated from WGS data.
Notably, due to multi-sample calling and noise present in the data, the kinship
coefﬁcient of unrelated samples is expected to be around 0.05. Hence, this is usually
applied as proximate to calculate relatedness.
cDNA analysis. RNA was isolated from ﬁbroblast cultures generated from skin
biopsiesusing an RNeasy minikit (Qiagen) according to the manufacturers

protocol. cDNA was produced using SuperScript® VILO™ cDNA Synthesis Kit
(Invitrogen). Two microliters of cDNA were used in a PCR reaction amplifying
ABCC9 exon 6–9 using primers as described in the Supplementary Methods. PCR
products were subsequently veriﬁed by Sanger sequencing.
Molecular biology and recombinant expression. For recombinant protein
expression and functional characterization, a 52 amino acid deletion (Ala386 to
Gln437; Δ8) equivalent to the human exon 8 coding region was engineered into
either a N-terminal Flag-tagged rat SUR2A construct (pcDNA_rSUR2A-Flag;
GenBank accession No. D83598.1), a wild-type rat SUR2A construct
(pCMV_SUR2A-WT; GenBank accession No. D83598.1) or a wild-type rat SUR2B
construct (pcDNA_rSUR2B-WT; GenBank accession No. AF019628.1). The rat
SUR2 sequence is 97% identical to human SUR2 and was used to allow for
comparison with an extensive number of previous studies of recombinant
SUR213,14,56–58. SUR2 cDNA (1 µg) was transiently transfected into Cosm6 cells59
(RRID: CVCL_8561) using Fugene 6 (Roche) alongside wild-type Kir6.2 (0.6 µg;
pcDNA3.1_mKir6.2; GenBank accession No. D50581.1). To mimic heterozygous
expression, Kir6.2 was co-transfected with a 1:1 ratio of SUR2A-WT and SUR2AΔ8
(0.5 µg:0.5 µg). Western blot analysis and radioactive rubidium efﬂux assays were
performed 48–72 h after transfection.
Western blot analysis of recombinant SUR2. Cosm6 cells were transfected with
GFP alone, Kir6.2 with Flag-tagged SUR2A-WT or Kir6.2 with Flag-tagged
SUR2AΔ8 (N-terminal Flag tag with amino acid sequence MDYKDDDDKGAP
was inserted prior to the SUR2A start codon). After 48 h, cells were harvested in
phosphate buffered saline (PBS; Gibco), pelleted, and lysed in 50 µl of PBS containing 1% Triton X-100 (Sigma) by mixing for 1 h at 4 oC. Cell lysate was mixed
with 2× SDS loading buffer, and was separated by electrophoresis using a precast
4–12% Bis-Tris Gel (Nupage). Gel contents were transferred to membranes using
an iBlot 2 (Thermo-Fisher). Membranes were ﬁrst incubated in a blocking solution
(PBS/1% TWEEN 20/0.4% milk; PBSTM) for 1 h at room temperature (RT) with
gentle shaking, before being washed (3× using PBS/TWEEN) and incubated in the
primary horseradish peroxidase-conjugated anti-Flag antibody (Anti-Flag M2HRP-conjugate Sigma # A8592; 1 in 5000 in PBSTM), or an anti-α actin antibody
(clone C4 MilliporeSigma # MAB1501;1 in 3000 in PBSTM) for 1 h/RT. Anti-actin
blots were washed (3× in PBSTM) and incubated with horseradish peroxidaseconjugated secondary antibody (Goat anti-mouse IgG antibody-HRP conjugate,
Santa Cruz Biotechnology # sc-2005; 1 in 5000 in PBSTM) for 1 h at room temperature. A Pierce ECL Western Blotting Substrate kit was used for chemiluminescence detection; blots were analyzed and protein density quantiﬁed using
ImageJ (NIH) and Excel (Microsoft). Actin and SUR2AΔ8 expression was normalized to values observed in WT SUR2A-Flag transfected cells in each independent experiment.
Rubidium (86Rb+) efﬂux assay. Cosm6 cells were plated and transfected in
12-well plates at sufﬁcient density to allow for ~75% conﬂuence on the day of
experimenting. Cells were loaded with radioactive 86Rb+ by incubation (> 6 h) with
DMEM media spiked with 1 µCi ml-1 86RbCl (PerkinElmer) at 37 °C/5% CO2.
After isotope loading, cells were washed in Ringer’s solution which contained (in
mM): 118 NaCl, 10 HEPES, 25 NaHCO3, 4.7 KCl, 1.2 KH2PO4, 2.5 CaCl2, and
1.2 MgSO4, and was supplemented with 2.5 mg/ml oligomycin and 1 mM 2-deoxyD-glucose to induce metabolic inhibition (MI), and incubated at room temperature
for a further 10 min. Cells were then washed and Ringer’s solution was added to
each well, before being collected and replaced at the deﬁned time points (2.5,
5, 12.5, 22.5, and 37.5 min). Cells were then lysed with 2% SDS to liberate
remaining intracellular 86Rb+ and sample radioactivity was determined by scintillation counting.
Cumulative 86Rb+ efﬂux was calculated from the total counts from each time
point. A time-dependent divergence from a mono-exponential efﬂux was observed,
as noted previously58, and thus rate constants were derived from exponential
functions ﬁt to early time points only (2.5–12.5 min). KATP-independent efﬂux rate
constants (k1) were obtained from GFP-only transfected cells using the equation:
Efflux ¼ 1ek1 :t ;

ð1Þ

The KATP-dependent efﬂux rate constant (k2) was obtained from KATP-transfected
cells using the equation:
Efflux ¼ 1  eððk1 :tÞþðk2 :tÞÞ ;

ð2Þ

where k1 was obtained from GFP-transfected cells (Eq. (1)), and the number of
active channels was assumed to be proportional to k2. Efﬂux-time data shown
represent the mean ± SEM from at least three independent experiments with
multiple internal replicates (N ≥ 3, n ≥ 4). The Mann–Whitney U test was used to
determine statistical signiﬁcance at a p- value < 0.05.
Patch clamp recording of recombinant channels. Cosm6 cells were transfected
with WT Kir6.2 (0.6 μg) and either WT SUR2A (1 μg), SUR2AΔ8 (1 μg), or a 1:1
ratio of WT and SUR2AΔ8 (0.5 μg: 0.5 μg), and 0.1 μg pcDNA3.1-eGFP to identify
transfected cells. In all, 48–72 h after transfection, excised inside out patch clamp
recordings were made. The membrane potential was voltage clamped at −50 mV.
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Symmetrical KINT solution which contained (in mM): 140 KCl, 10 HEPES, 1
EGTA (pH 7.4 with KOH) was used for pipette and bath solutions. ATP and
pinacidil were applied (in the presence of 0.5 mM free Mg2+, calculated using
CaBuf (Katholieke Universiteit Leuven) using a Dynaﬂow Resolve perfusion chip
(Cellectricon). Experiments were performed at 20–22 °C. KATP channel currents in
the absence and presence of nucleotides and pinacidil were normalized to the basal
current in KINT, and dose–response data were ﬁt with a four-parameter Hill ﬁt
according to Eq. (3), using the Data Solver Function in Microsoft Excel, where the
current in KINT = Imax = 1; Imin is the normalized minimum current observed in
ATP; [X] refers to the concentration of ATP; IC50 is the concentration of halfmaximal inhibition; and H denotes the Hill coefﬁcient.
Normalized current ¼ Imin þ ðImax  IminÞ=ð1 þ ð½X=IC50 ÞH Þ:

ð3Þ

Generation of the SUR2 LoF mouse. All mouse studies were performed in
compliance with the standards for the care and use of animal subjects deﬁned in
the NIH Guide for the Care and Use of Laboratory Animals, and were reviewed
and approved by the Washington University Institutional Animal Care and Use
Committee. SUR2-STOP mice were generated using CRISPR/Cas9-mediated
genome engineering60. In mice in which an attempt was made to generate a Cantú
Syndrome-associated missense mutation, an artefactual indel mutation in ABCC9
(c.3446_3450delACTTCinsGA) was identiﬁed in one founder individual (B6CBA
F1/J background), which results in the introduction of a premature stop codon (p.
Y1148Stop). This founder (termed heterozygous SUR2-STOP) was viable and
fertile and was crossed with C57BL/6J mice to generate F1 SUR2wt/STOP mice.
gDNA was isolated from F1 mouse tails, and PCR was used to verify the presence
of the indel mutation in positive offspring. One positively identiﬁed SUR2wt/STOP
F1 mouse was selected, and further crossed against C57BL/6J to generate F2
SUR2wt/STOP, which were in turn intercrossed to generate F3 homozygous
SUR2STOP/STOP (hereafter referred to as SUR2-STOP) and wild-type and heterozygous littermates, which were used for experiments.
Electrophysiological recordings of isolated myocytes. Ventricular myocytes
were isolated from adult mice as previously described61. Inside–out patch clamp
recordings were made in symmetrical pipette and bath KINT solutions which
contained (in mM): 140 KCl, 10 HEPES, 1 EGTA (pH 7.4). Solution exchange was
achieved using a Dynaﬂow Resolve perfusion chip (Fluicell). MgATP and pinacidil
(both Sigma) were applied as indicated. Free Mg2+ was maintained at 0.5 mM by
supplementing ATP-containing solutions with MgCl2, where necessary. Recording
electrodes were formed from sodalime hematocrit glass (Kimble) and had a
resistance of 1–1.4 MΩ when ﬁlled. Currents were recorded at −50 mV, sampled at
3 kHz, and ﬁltered at 1 kHz using an Axopatch 700B and Digidata 1200 (Molecular
Devices). KATP current was calculated as the difference between the current in the
absence of nucleotides and in the presence of a fully inhibiting concentration of
10 mM MgATP.
Vascular smooth muscle cells were acutely isolated form the descending
thoracic aorta, as previously described42. Whole-cell patch clamp recordings were
made in an initial Na+ bath solution (which contained, in mM): NaCl 136, KCl 6,
CaCl2 2, MgCl2 1, HEPES 10, and glucose 10 (pH 7.4) before switching to a K +
bath solution which contained (in mM) KCl 140, CaCl2 2, MgCl2 1, HEPES 10, and
glucose 10 pH 7.4, in the absence and presence of pinacidil and glibenclamide as
indicated. The pipette solution contained (in mM) potassium aspartate 110, KCl
30, NaCl 10, MgCl2 1, HEPES 10, CaCl2 0.5, K2HPO4 4, and EGTA 5, with pH
adjusted to 7.2 with KOH. The glibenclamide sensitive current density at a holding
potential of −70 mV was taken as a measure of KATP channel activity.
The data were analyzed using Clampﬁt (Molecular Devices) and Excel
(Microsoft) and are presented as individual replicates in scatter plots, alongside
mean ± SEM. The two-tailed t test was used to determine statistical signiﬁcance at a
p-value < 0.05 using the RealStatistics add-in for Microsoft Excel.
Mouse echocardiography. Echocardiography was performed on adult (5-monthold) mice, as previously described62. Images were acquired using the Visual Sonics
Vevo 770 Imaging System (Visual Sonics Inc., Toronto, Canada) and analyzed with
Visual Sonics software. Mice were lightly anesthetized using Avertin and M-mode
images of the parasternal long axis were obtained, from which measurements of
fractional shortening, left ventricular mass, and left ventricular internal dimension
in diastole (LVIDd) were calculated. Left ventricular mass and LVIDd were normalized to the mouse body weight and length (tip of nose to base of tail) for
statistical comparisons. One-way ANOVA followed by post hoc Tuket test or Twotailed t tests were used to determine statistical signiﬁcance using the RealStatistics
add-in for Microsoft Excel, as described.
Multiple-trial inverted screen test. The procedure involved a modiﬁcation of a
previously published single-trial method that had been used to demonstrate
impaired strength in a mutant mouse model of muscular dystrophy31. This
methodology was adapted to evaluate deﬁcits in strength related to decreases in
physical endurance, which involved conducting multiple test trials administered in
a single day. The apparatus was a wire-mesh screen (16 squares per 10 cm) that was
elevated ~50 cm. A trial consisted of placing an adult (2–3-month-old) SUR216

STOP mouse, heterozygote (Het) SUR2-STOP mouse, or a wild-type littermate
control on the screen that was inclined to 60° with its head oriented down toward
the base of the screen. After the mouse was stabilized on the screen, it was slowly
inverted resulting in the mouse hanging upside down from the screen. Soft bedding
was placed underneath the mouse to help protect it from injury. The time a mouse
remained hanging upside down following inversion of the screen was recorded
during an initial 3-min test trial. After the ﬁrst trial, a mouse was placed into a
holding cage for 5 min after which two more trials were conducted with 5 min
being spent in the holding cage between trials. After completing the three trials, a
mouse was placed back into the holding cage where it remained for 44 min, which
was followed by the same 3 × 3-min test trial procedure described above. If a mouse
remained hanging from the screen for the full 3 min duration, it was removed from
the screen and assigned a value of 180 s. The time a mouse remained hanging
upside from the screen (3-min maximum) was analyzed for each of the six trials as
well as the total duration summed across all six trials.
Behavioral and cognitive testing of SUR2-STOP mice. Cognitive and other
behavioral functions were assessed in adult (4–5-month-old) SUR2-STOP mice
and wild-type littermates by conducting a battery of tests to evaluate ambulatory
activity, emotionality, sensorimotor capabilities, learning and memory, and
anxiety-like behaviors. The battery included the following tests (in order): 1-h
locomotor activity; a series of seven simple sensorimotor measures; the Morris
water maze, object recognition; and elevated plus maze, respectively. Full
descriptions of these procedures are provided in the Supplementary Methods.
Blood pressure recordings in SUR2-STOP mice. Arterial blood pressures were
measured in 12-month-old SUR2-STOP mice and WT littermates anesthetized
with 1.5% isoﬂurane. The left carotid artery was catherized and a Millar pressure
transducer advanced to the ascending aorta. Pressures were recorded using Powerlab data acquisition (ADInstruments), and mean arterial pressure (MAP) was
calculated using LabChart 7 (ADInstruments).
Zebraﬁsh maintenance. All zebraﬁsh experiments were conducted under the
guidelines of the animal welfare committee of the Royal Netherlands Academy of
Arts and Sciences (KNAW) and were approved by the local ethics committee at the
Royal Dutch Academy of Sciences (KNAW). Adult zebraﬁsh (Danio rerio) were
maintained at 28 °C and subjected to the 14-h light/10-h dark cycle. Embryos were
produced by natural mating and kept in a humidiﬁed incubator at 28 °C63. All
CrispR/Cas9 injections were performed in the wild-type strain Tübingen longﬁn.
CRISPR/Cas9 design and embryo injections. A target site within the abcc9
open-reading frame was chosen using CHOPCHOP (http://chopchop.cbu.uib.no/).
sgRNA template was purchased at Integrated DNA Technologies (IDT) as standard
desalted same-day oligos and synthesis was carried out using the Ambion
MEGAscript T7 or SP6 kits (Ambion). Puriﬁcation of the in vitro synthesized
mRNA was achieved with the RNeasy Mini Kit (Qiagen)64. gRNA and Cas9encoding mRNA were co-injected into one-cell stage zebraﬁsh embryos. Each
embryo was injected with 2 nl of solution containing ~12.5 ng μl−1 of sgRNA and
~300 ng μl−1 of Cas9 mRNA. Injected embryos were grown to adulthood to generate “founder” ﬁsh (F0), and screened for germline transmission of CRISPRinduced indel mutations using an adapted method for detecting simple sequencelength polymorphisms (SSLPs). Each putative founder adult ﬁsh was crossed with a
wild-type adult ﬁsh (F1). Sequencing analysis conﬁrmed successful introduction of
13n deletion and segregation in a Mendelian fashion. Homozygous ﬁsh (F2) were
generated by inbreeding heterozygous mutant carriers.
Quantitative RT-PCR. Zebraﬁsh larvae at 5 dpf were pooled in groups of 60 (three
different groups for WT and four groups for homozygous mutants) and homogenized. RNA was puriﬁed using Trizol following standard procedures and cDNA
synthesized using High-Capacity cDNA Reverse Transcription Kit. qPCR was
performed using a StepOne Real Time PCR System (Applied Bioscience) and
PrimeTime qPCR primer/probe assays, as detailed in the Supplementary Methods
(Integrated DNA Technologies). Relative gene expression (2-ΔΔCt) was calculated
by normalizing abcc9 expression to the mean expression observed in WT pools
using Gapdh as a reference gene and the Pfafﬂ Method65.
Isolation of adult zebraﬁsh ventricular myocytes. For isolation of cardiomyocytes, ~1-year-old animals were anaesthetized by transfer into ice water before they
were decapitated. After removal of the skin and opening of the pericardial sac, the
hearts were harvested and both bulbous arteriosus and atrium were removed.
Ventricles from three to four ﬁsh were pooled together and placed in an epi
containing perfusion buffer: (mM) 10 HEPES, 30 Taurine, 5.5 Glucose, 10 BDM in
PBS. Ventricular myocytes were obtained by enzymatic dissociation (perfusion
buffer supplemented with 12.5 μM CaCl2, 5 mg/ml collagenase II and IV) at 32 °C,
and 800 rpm for 40 min. Dissociation was ended by transfer to stopping buffer
(perfusion buffer supplemented with 10% (vol/vol) FBS, 12.5 μM CaCl2, 5 mg/ml
BSA). Cells were dispersed by gentle trituration using a Pasteur pipette.
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Electrophysiological recordings of isolated myocytes. Pipettes were made from
soda lime glass microhematocrit tubes (Kimble) and had a resistance of 1–2 MΩ
when ﬁlled with pipette solution. All recordings were made in symmetrical KINT
solution ((mM) 140 KCl, 10 HEPES, 0.5 EGTA (pH 7.4 with KOH)). ATP (Sigma)
was applied as indicated. Free Mg2+ was maintained at 0.5 mM by supplementing
ATP-containing solutions with MgCl2 where necessary. Currents were recorded at
−50 mV, sampled at 3 kHz, and ﬁltered at 1 kHz using an Axopatch 1D and
Digidata 1322 A (Molecular Devices). KATP current was calculated as the difference
between the current in the absence of nucleotides and in the presence of a fully
inhibiting concentration of 5 mM ATP. The data were analyzed using Clampﬁt
(Molecular Devices) and Excel (Microsoft), and are presented as individual replicates in scatter plots, alongside mean ± SEM.

Heart extraction and hematoxylin and eosin (H&E) staining. Adult zebraﬁsh
hearts were dissected and ﬁxed in 4% paraformaldehyde (in phosphate buffer with
4% sucrose) at 4 °C overnight and subjected to parafﬁn embedding and sectioning
at 10 μm intervals. Heart sections were stained with H&E following standard
procedures. Six ﬁshes were used for each genotype. Image acquisition was conducted using a Leica DM4000 B LED upright automated microscope.
TUNEL assay. TUNEL apoptosis staining was performed on 10 µm cryosections
and detected using the in situ cell death detection kit from Roche (Mannheim,
Germany) according to the manufacturer’s instructions. Nuclei are shown by DAPI
(4′,6-diamidino-2-phenylindole) staining. Confocal images were acquired using a
Leica Sp8 confocal microscope.

Larval locomotor assay. The Viewpoint Zebrabox system (Viewpoint Behaviour
Technology, Lyon, France) was used to evaluate larval locomotor activity in 5 dpf
zebraﬁsh larvae. Larvae were transferred to a 48-well plate with 500 μl of embryo
medium, placed into the Zebrabox and subjected to a 30 min acclimatization
period to the plate and Zebrabox environment. A total of 24 replicates (one embryo
placed individually in each plate well per replicate) were used per genotype.
Behavior was monitored at 28.5° using a ZebraBox system (ViewPoint Behaviour
Technology) consisting of a soundproof chamber with an infrared camera capable
of recording 60 frames per second; analyses were performed using Zebralab
locomotion tracking software (ViewPoint Behavior Technology). The integration
period was set to 30 s for the 10-min duration of the experiment. A nontransparent
background mode with a detection threshold of 20 was used and a minimum
velocity of 2 mm s−1 was deﬁned as record threshold of inactivity in order to
remove system noise. A movement was considered “small” when individuals
moved <10 mm/s. The larval locomotor assay consisted of a 5 min baseline
recording. The total movement was recorded, then, quantiﬁed using ZebraLab
software (Viewpoint, Lyon, France) and plotted in “actinteg” units, which is the
sum of all pixel changes detected during the experimental period66. In addition,
from the data recorded, the ZebraLab software calculated several parameters such
as total swimming distance (TSD) and total swimming time (TST). The data were
compiled and mean activity, TSD or TST for every genotype during each integration period calculated. The data were pooled together from three independent
experiments at the same conditions. All experiments were performed comparing
SUR2-STOP and its WT siblings. All embryos analyzed originated from group
matings of adult zebraﬁsh.

Statistical analysis. Rubidium ﬂux, patch clamp electrophysiology and echocardiography data were analyzed using two-tailed t test or Mann–Whitney U test as
described. For the inverted screen test of mice, data were analyzed using a repeated
measures (rm) ANOVA model that contained one between-subjects variable
(genotype) and two within-subjects variables (trials and sessions), followed by
pairwise comparison by two-tailed t test with Bonferroni correction. Behavioral
tests in mice were analyzed using a repeated measures (rm) ANOVA model that
contained two between-subjects variable (genotype and sex) and one withinsubjects variable (trial block). The data are presented as mean ± SEM.
For zebraﬁsh studies sample size was not predetermined by statistical analysis.
In all experiments involving zebraﬁsh embryos, selection was random for scoring.
Exact numbers of analyzed embryos are reported at relevant locations in the main
text or ﬁgure legends. Statistical analysis was carried out with Prism (GraphPad).
Distribution of the data sets was tested by D’Agostino–Pearson omnibus normality
test. Depending on the outcome of this test, comparison of two conditions with each
other was carried out using a Student’s two-tailed t test or Mann–Whitney twotailed U test throughout the manuscript. All values are expressed as mean ± SEM.

In vivo high-speed imaging. Image acquisition was conducted using a Hamamatsu C9300-221 high-speed CCD camera (Hamamatsu Photonics) at 150 fps
mounted on a Leica DM IRBE inverted microscope (Leica Microsystems) using
Hokawo 2.1 imaging software (Hamamatsu Photonics). Image analysis was subsequently carried out with ImageJ (http://rsbweb.nih.gov/ij/, last accessed
November 2017). For analysis of cardiac function, adult zebraﬁsh heterozygous for
abcc9 KO were interbred, and genotype identiﬁed by sanger sequencing post
imaging. High-speed brightﬁeld image sequences of the embryonic zebraﬁsh heart
were acquired for zebraﬁsh at age of 5 days post fertilization (dpf). To inhibit
pigmentation, 0.003 %(v/v) 1-phenyl-2-thiourea was added to the embryo medium
at the Prim-5 stage (about 24 h post fertilization (hpf)). After being anaesthetized
in 16 mg/ml tricaine (MilliporeSigma) in E3 medium zebraﬁsh embryos were
mounted in dorsal position in small microscopic chambers ﬁlled with 0.25% (w/v)
agarose (Invitrogen) prepared in the same concentration of anesthetic. Zebraﬁsh
hearts were imaged for 10 s (~30 cardiac cycles) at 28 °C ± 0.2 °C.

Data availability

Cardiac dimensions and function in SUR2-STOP zebraﬁsh. The time interval
between three heart beats was measured, and the heart rate (bpm) was calculated in
triplicates. Sequential still frames from high-speed movies were used to outline the
perimeter of the ventricle. Measurement analysis was carried out by “ﬁt-to-ellipse”
algorithm, which calculates the center of mass and subsequently the best ﬁtting
ellipse. The long axis length (a) and short axis length (b) at diastole and systole
were determined and used to calculate ventricular end-systolic (ESV) and diastolic
volumes (EDV) in triplicates applying the formula: V = 4/3πab2. The stroke
volume was calculated as the difference between three ventricular EDVs and ESVs.
Cardiac output was obtained by multiplying the heart rate with stroke volume. The
percent shortening fraction (SF) was calculated using the formula: SF = (length at
diastole − length at systole)/(length at diastole) × 100. Fractional area change
(FAC) was calculated as follows: FAC = (area at diastole − area at systole)/(area at
diastole) × 100. Measurements were performed blindly.

Web resources. For CHOPCHOP, see http://chopchop.cbu.uib.no/; for Ensembl,
see http://www.ensembl.org/; for ExAC Browser, see http://exac.broadinstitute.org/;
for gnomAD, see https://gnomad.broadinstitute.org/; for OMIM, see https://www.
omim.org/; for UCSC, see https://genome.ucsc.edu/.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.

The authors declare that all data supporting the ﬁndings of this study are available within
the paper and its Supplementary Information. Source data for Figs. 3, 4, 5, 6, and 7, and
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